• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在肿瘤基因组测序研究中识别癌症驱动基因。

Identifying cancer driver genes in tumor genome sequencing studies.

机构信息

Biometric Research Branch, National Cancer Institute, Bethesda, MD 20892-7434, USA.

出版信息

Bioinformatics. 2011 Jan 15;27(2):175-81. doi: 10.1093/bioinformatics/btq630. Epub 2010 Dec 17.

DOI:10.1093/bioinformatics/btq630
PMID:21169372
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3018819/
Abstract

MOTIVATION

Major tumor sequencing projects have been conducted in the past few years to identify genes that contain 'driver' somatic mutations in tumor samples. These genes have been defined as those for which the non-silent mutation rate is significantly greater than a background mutation rate estimated from silent mutations. Several methods have been used for estimating the background mutation rate.

RESULTS

We propose a new method for identifying cancer driver genes, which we believe provides improved accuracy. The new method accounts for the functional impact of mutations on proteins, variation in background mutation rate among tumors and the redundancy of the genetic code. We reanalyzed sequence data for 623 candidate genes in 188 non-small cell lung tumors using the new method. We found several important genes like PTEN, which were not deemed significant by the previous method. At the same time, we determined that some genes previously reported as drivers were not significant by the new analysis because mutations in these genes occurred mainly in tumors with large background mutation rates.

AVAILABILITY

The software is available at: http://linus.nci.nih.gov/Data/YounA/software.zip.

摘要

动机

在过去的几年中,已经进行了主要的肿瘤测序项目,以鉴定肿瘤样本中含有“驱动”体细胞突变的基因。这些基因被定义为那些非同义突变率明显高于从沉默突变估计的背景突变率的基因。已经使用了几种方法来估计背景突变率。

结果

我们提出了一种新的方法来鉴定癌症驱动基因,我们相信这提供了更高的准确性。新方法考虑了突变对蛋白质的功能影响、肿瘤之间背景突变率的差异以及遗传密码的冗余性。我们使用新方法重新分析了 188 个非小细胞肺癌肿瘤中 623 个候选基因的序列数据。我们发现了一些重要的基因,如 PTEN,以前的方法认为它们不显著。同时,我们确定了一些先前被报道为驱动基因的基因在新的分析中并不显著,因为这些基因的突变主要发生在背景突变率较高的肿瘤中。

可用性

该软件可在以下网址获得:http://linus.nci.nih.gov/Data/YounA/software.zip。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/632f/3018819/67d1adfbe9bb/btq630f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/632f/3018819/56c73c2f134e/btq630f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/632f/3018819/67d1adfbe9bb/btq630f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/632f/3018819/56c73c2f134e/btq630f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/632f/3018819/67d1adfbe9bb/btq630f2.jpg

相似文献

1
Identifying cancer driver genes in tumor genome sequencing studies.在肿瘤基因组测序研究中识别癌症驱动基因。
Bioinformatics. 2011 Jan 15;27(2):175-81. doi: 10.1093/bioinformatics/btq630. Epub 2010 Dec 17.
2
Estimating the order of mutations during tumorigenesis from tumor genome sequencing data.从肿瘤基因组测序数据估算肿瘤发生过程中的突变顺序。
Bioinformatics. 2012 Jun 15;28(12):1555-61. doi: 10.1093/bioinformatics/bts168. Epub 2012 Apr 6.
3
Driver gene mutations based clustering of tumors: methods and applications.基于驱动基因突变的肿瘤聚类:方法与应用。
Bioinformatics. 2018 Jul 1;34(13):i404-i411. doi: 10.1093/bioinformatics/bty232.
4
Differential analysis between somatic mutation and germline variation profiles reveals cancer-related genes.体细胞突变和种系变异图谱之间的差异分析揭示了癌症相关基因。
Genome Med. 2017 Aug 25;9(1):79. doi: 10.1186/s13073-017-0465-6.
5
DrGaP: a powerful tool for identifying driver genes and pathways in cancer sequencing studies.DrGaP:一种在癌症测序研究中识别驱动基因和途径的强大工具。
Am J Hum Genet. 2013 Sep 5;93(3):439-51. doi: 10.1016/j.ajhg.2013.07.003. Epub 2013 Aug 15.
6
Comparison of different functional prediction scores using a gene-based permutation model for identifying cancer driver genes.基于基因排列模型的不同功能预测评分比较,用于鉴定癌症驱动基因。
BMC Med Genomics. 2019 Jan 31;12(Suppl 1):22. doi: 10.1186/s12920-018-0452-9.
7
Cancer driver gene discovery through an integrative genomics approach in a non-parametric Bayesian framework.在非参数贝叶斯框架下通过综合基因组学方法发现癌症驱动基因。
Bioinformatics. 2017 Feb 15;33(4):483-490. doi: 10.1093/bioinformatics/btw662.
8
Integrated RNA and DNA sequencing improves mutation detection in low purity tumors.整合RNA和DNA测序可提高低纯度肿瘤中的突变检测率。
Nucleic Acids Res. 2014 Jul;42(13):e107. doi: 10.1093/nar/gku489. Epub 2014 Jun 26.
9
Design and analysis issues in genome-wide somatic mutation studies of cancer.癌症全基因组体细胞突变研究中的设计与分析问题
Genomics. 2009 Jan;93(1):17-21. doi: 10.1016/j.ygeno.2008.07.005. Epub 2008 Aug 23.
10
LowMACA: exploiting protein family analysis for the identification of rare driver mutations in cancer.低MACA:利用蛋白质家族分析来识别癌症中的罕见驱动突变。
BMC Bioinformatics. 2016 Feb 9;17:80. doi: 10.1186/s12859-016-0935-7.

引用本文的文献

1
Identifying potential risk genes for clear cell renal cell carcinoma with deep reinforcement learning.运用深度强化学习识别肾透明细胞癌的潜在风险基因。
Nat Commun. 2025 Apr 15;16(1):3591. doi: 10.1038/s41467-025-58439-5.
2
Stable Dual miR-143 and miR-506 Upregulation Inhibits Proliferation and Cell Cycle Progression.稳定的双miR-143和miR-506上调抑制细胞增殖和细胞周期进程。
Int J Mol Sci. 2024 Apr 17;25(8):4432. doi: 10.3390/ijms25084432.
3
Identification of cancer driver genes based on hierarchical weak consensus model.基于层次化弱共识模型的癌症驱动基因识别

本文引用的文献

1
Comprehensive characterization of the DNA amplification at 13q34 in human breast cancer reveals TFDP1 and CUL4A as likely candidate target genes.全面描述人类乳腺癌中 13q34 区的 DNA 扩增,揭示 TFDP1 和 CUL4A 可能是候选靶基因。
Breast Cancer Res. 2009;11(6):R86. doi: 10.1186/bcr2456. Epub 2009 Dec 8.
2
Somatic mutations affect key pathways in lung adenocarcinoma.体细胞突变影响肺腺癌的关键通路。
Nature. 2008 Oct 23;455(7216):1069-75. doi: 10.1038/nature07423.
3
Gain and loss of phosphorylation sites in human cancer.人类癌症中磷酸化位点的获得与丧失
Health Inf Sci Syst. 2024 Mar 6;12(1):21. doi: 10.1007/s13755-024-00279-6. eCollection 2024 Dec.
4
Global metabolomics revealed deviations from the metabolic aging clock in colorectal cancer patients.全球代谢组学揭示了结直肠癌患者代谢衰老时钟的偏差。
Theranostics. 2024 Feb 4;14(4):1602-1614. doi: 10.7150/thno.87303. eCollection 2024.
5
Proteomic analysis of small extracellular vesicles unique to cervical cancer.宫颈癌特有的小细胞外囊泡的蛋白质组学分析
Transl Cancer Res. 2023 Nov 30;12(11):3113-3128. doi: 10.21037/tcr-23-517. Epub 2023 Nov 2.
6
Computational Approaches: A New Frontier in Cancer Research.计算方法:癌症研究的新前沿。
Comb Chem High Throughput Screen. 2024;27(13):1861-1876. doi: 10.2174/0113862073265604231106112203.
7
Identifying Cancer Driver Pathways Based on the Mouth Brooding Fish Algorithm.基于口育鱼算法识别癌症驱动通路。
Entropy (Basel). 2023 May 24;25(6):841. doi: 10.3390/e25060841.
8
Polymorphisms in and genes and their association with feed conversion ratio in Hu sheep.湖羊中**[具体基因名称缺失]**基因的多态性及其与饲料转化率的关联
Front Vet Sci. 2023 Jan 5;9:1010045. doi: 10.3389/fvets.2022.1010045. eCollection 2022.
9
DGRanker: Cancer Driver Gene Detection in Human Transcriptional Regulatory Network.DGRanker:人类转录调控网络中的癌症驱动基因检测
Iran J Biotechnol. 2022 Apr 1;20(2):e3066. doi: 10.30498/ijb.2022.289013.3066. eCollection 2022 Apr.
10
Identification of key somatic oncogenic mutation based on a confounder-free causal inference model.基于无混杂因素因果推理模型的关键体细胞致癌突变鉴定。
PLoS Comput Biol. 2022 Sep 22;18(9):e1010529. doi: 10.1371/journal.pcbi.1010529. eCollection 2022 Sep.
Bioinformatics. 2008 Aug 15;24(16):i241-7. doi: 10.1093/bioinformatics/btn267.
4
Frequent mutations in the neurotrophic tyrosine receptor kinase gene family in large cell neuroendocrine carcinoma of the lung.肺大细胞神经内分泌癌中神经营养性酪氨酸受体激酶基因家族的频繁突变
Hum Mutat. 2008 May;29(5):609-16. doi: 10.1002/humu.20707.
5
The genomic landscapes of human breast and colorectal cancers.人类乳腺癌和结直肠癌的基因组图谱。
Science. 2007 Nov 16;318(5853):1108-13. doi: 10.1126/science.1145720. Epub 2007 Oct 11.
6
Patterns of somatic mutation in human cancer genomes.人类癌症基因组中的体细胞突变模式。
Nature. 2007 Mar 8;446(7132):153-8. doi: 10.1038/nature05610.
7
Nasopharyngeal carcinoma: molecular biomarker discovery and progress.鼻咽癌:分子生物标志物的发现与进展
Mol Cancer. 2007 Jan 2;6:1. doi: 10.1186/1476-4598-6-1.
8
The consensus coding sequences of human breast and colorectal cancers.人类乳腺癌和结直肠癌的共有编码序列。
Science. 2006 Oct 13;314(5797):268-74. doi: 10.1126/science.1133427. Epub 2006 Sep 7.
9
Statistical analysis of pathogenicity of somatic mutations in cancer.癌症中体细胞突变致病性的统计分析。
Genetics. 2006 Aug;173(4):2187-98. doi: 10.1534/genetics.105.044677. Epub 2006 Jun 18.
10
Hypermethylation of RASSF1A and BLU tumor suppressor genes in non-small cell lung cancer: implications for tobacco smoking during adolescence.非小细胞肺癌中RASSF1A和BLU肿瘤抑制基因的高甲基化:对青春期吸烟的影响
Int J Cancer. 2005 Mar 20;114(2):219-23. doi: 10.1002/ijc.20714.